Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.

Hannah C TimminsDavid MizrahiTiffany LiMatthew C KiernanDavid GoldsteinSusanna B Park

Published in: Journal of cancer survivorship : research and practice (2021)

Better understanding of CIPN risk profiles may inform personalized medicine strategies and help elucidate pathophysiological mechanisms which could be targeted for neuroprotection.

Keyphrases

chemotherapy induced
newly diagnosed
end stage renal disease
ejection fraction
metabolic syndrome
cardiovascular disease
prognostic factors
physical activity
brain injury
type diabetes
patient reported outcomes
drug delivery
metastatic breast cancer
breast cancer risk